📚 PASS Research Analyst Certification Examination Difficulty: Beginner ℹ️ Info   ~5 min read
📌 Chapter 2.1 — Introduction to Securities and Securities Market

Imagine you are drafting an investment note on a diversified financial conglomerate. You notice the company’s recent earnings report highlights substantial inflows from ‘Unit Linked Insurance Plans’ (ULIPs) and mutual fund units. If you carelessly aggregate these inflows under a single category of ‘securities-based revenue,’ your valuation model will likely miscalculate the firm’s regulatory risk profile. The legal distinction between these products is not merely a bureaucratic formality; it determines the governing framework, capital requirement norms, and investor protection mechanisms relevant to your financial analysis.

The Securities Contracts (Regulation) Act, 1956 (SCRA) serves as the primary bedrock for defining what constitutes a security in the Indian market. It includes shares, bonds, debentures, and derivatives—instruments meant for investment and trading where price discovery is driven by secondary market activity. Conversely, insurance products like ULIPs or traditional endowment plans are governed by the Insurance Regulatory and Development Authority of India (IRDAI).

While a ULIP invests part of the premium into equity or debt markets, the product itself is a contract of insurance, not a tradable security. As an analyst, misclassifying these leads to erroneous assumptions regarding liquidity, taxation, and market accessibility.

Consider the impact of this oversight on risk assessment. Securities under SEBI’s purview are subject to stringent disclosure norms, circuit filters, and standardized settlement cycles, which facilitate high-velocity trading and transparent valuation. Insurance products, however, are long-term contracts designed for protection, often featuring exit loads, surrender charges, and lock-in periods that impede liquidity. If you incorporate insurance-based assets into a liquidity-adjusted valuation model as if they were exchange-traded stocks, you will fundamentally underestimate the capital-at-risk for the retail investor.

Understanding this regulatory boundary ensures your sector research remains legally sound and analytically rigorous.

To master this, one must view the landscape through the lens of regulatory jurisdiction. Securities provide transferable ownership or debt claims meant to be traded on platforms like the NSE or BSE. Insurance, while containing investment features, serves a risk-transfer function that is structurally distinct from the capital-raising function of the securities market.

By maintaining this separation, you ensure that your assessment of a company’s business model—and the inherent regulatory risk that comes with it—remains accurate for institutional and retail clients alike. Precision in classification is the hallmark of a professional analyst who understands that market architecture defines the rules of the game.

Nuance

⚠️ Nuance
A common pitfall is assuming that any product with an ‘investment component’—such as an insurance policy—automatically qualifies as a security. Candidates often confuse the underlying assets of a policy, like the equity-heavy corpus of a ULIP, with the policy instrument itself. An analyst must recognize that the ‘security’ label applies only to the underlying assets, not the insurance contract. Conflating these leads to errors in analyzing product compliance and the regulatory hurdles associated with selling them to the public.

Check Your Understanding

Practice Question 1

An analyst is reviewing a product portfolio for a firm and must identify which instrument falls outside the regulatory definition of a security under the SCRA, 1956. Which of the following should the analyst exclude?

Practice Question 2

Which entity holds the primary regulatory authority over insurance-based products in the Indian financial system?

This is a companion read for Section 2.1 — Introduction to Securities and Securities Market from PASS Research Analyst Certification Examination by Akhilesh Gururani, available on Amazon Kindle.

Copyright © 2026 Akhilesh Gururani. All rights reserved.